Skip to main content

Advertisement

Log in

Discovery of immune-related diagnostic biomarkers and construction of diagnostic model in varies polycystic ovary syndrome

  • General Gynecology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Aims

The various diagnostic criteria for polycystic ovary syndrome (PCOS) raised problem for PCOS research worldwide. PCOS has been demonstrated to be significantly associated with immune response. We aimed to identify several immune-related biomarkers and construct a nomogram model for diagnosis in PCOS.

Methods

The mRNA expression data were downloaded from Gene Expression Omnibus (GEO) database. Significant immune-related genes were identified to be the biomarkers for the diagnosis of PCOS using random forest model (RF), support vector machine model (SVM) and generalized linear model (GLM). The key biomarkers were selected from the optimal model and were utilized to construct a diagnostic nomogram. Receiver operating characteristic (ROC) curves was used to evaluate diagnostic ability of nomogram. Moreover, the relative proportion of 22 immune cell types was calculated by CIBERSORT algorithm.

Results

Four immune-related biomarkers (cAMP, S100A9, TLR8 and IL6R) were demonstrated to be highly expressed in PCOS. The nomogram constructed on the ground of the four key biomarkers showed perfect performance in diagnosis of PCOS, whose AUC were greater than 0.7. Higher infiltrating abundance of neutrophils, resting NK cells and activated dendritic cells were observed in PCOS and were tightly associated with the four key biomarkers.

Conclusions

This study identified several immune-related diagnostic biomarkers for PCOS patients. The diagnostic nomogram constructed based the biomarkers provide a theory foundation for clinical application. Multiple immune cells were associated with the expression of these four biomarkers and might played a vital role in the procession of PCOS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Data availability

Not applicable.

References

  1. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF (2009) The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91(2):456–488

    Article  Google Scholar 

  2. Ganie MA, Vasudevan V, Wani IA, Baba MS, Arif T, Rashid A (2019) Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India. Indian J Med Res 150(4):333–344

    Article  CAS  Google Scholar 

  3. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81(1):19–25

    Article  Google Scholar 

  4. Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R (2016) Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril 106(1):6–15

    Article  Google Scholar 

  5. Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK (2013) Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 98(12):4565–4592

    Article  CAS  Google Scholar 

  6. Witchel SF, Burghard AC, Tao RH, Oberfield SE (2019) The diagnosis and treatment of PCOS in adolescents: an update. Curr Opin Pediatr 31(4):562–569

    Article  Google Scholar 

  7. Escobar-Morreale HF, Luque-Ramírez M, San Millán JL (2005) The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocr Rev 26(2):251–282

    Article  CAS  Google Scholar 

  8. Zhang T, Tian F, Huo R, Tang A, Zeng Y, Duan YG (2017) Detection of dendritic cells and related cytokines in follicular fluid of patients with polycystic ovary syndrome. Am J Reprod Immunol. https://doi.org/10.1111/aji.12717

    Article  PubMed  Google Scholar 

  9. Liu Y, Liu H, Li Z, Fan H, Yan X, Liu X, Xuan J, Feng D, Wei X (2021) The release of peripheral immune inflammatory cytokines promote an inflammatory cascade in pcos patients via altering the follicular microenvironment. Front Immunol 12:685724

    Article  CAS  Google Scholar 

  10. González F (2012) Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids 77(4):300–305

    Article  Google Scholar 

  11. Hu C, Pang B, Ma Z, Yi H (2020) Immunophenotypic profiles in polycystic ovary syndrome. Mediators Inflamm 2020:5894768

    Article  Google Scholar 

  12. Yi W, Li X, Chen K, Li J, Chen K, Pan A (2020) Effect of rNA interference on Oatp3a1 gene expression on biological characteristics and immune factors of ovarian granulosa cells in rats with PCOS. Am J Transl Res 12(8):4659–4668

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Roh EY, Yoon JH, Song EY, Kim JJ, Hwang KR, Seo SH, Shin S (2017) Single nucleotide polymorphisms in the TGF-β1 gene are associated with polycystic ovary syndrome susceptibility and characteristics: a study in Korean women. J Assist Reprod Genet 34(1):139–147

    Article  Google Scholar 

  14. Zhao J, Xu J, Wang W, Zhao H, Liu H, Liu X, Liu J, Sun Y, Dunaif A, Du Y, Chen ZJ (2018) Long non-coding RNA LINC-01572:28 inhibits granulosa cell growth via a decrease in p27 (Kip1) degradation in patients with polycystic ovary syndrome. EBioMedicine 36:526–538

    Article  Google Scholar 

  15. Kenigsberg S, Bentov Y, Chalifa-Caspi V, Potashnik G, Ofir R, Birk OS (2009) Gene expression microarray profiles of cumulus cells in lean and overweight-obese polycystic ovary syndrome patients. Mol Hum Reprod 15(2):89–103

    Article  CAS  Google Scholar 

  16. Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD (2012) The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28(6):882–883

    Article  CAS  Google Scholar 

  17. Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK (2015) limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43(7):e47–e47

    Article  Google Scholar 

  18. Wang L, Cao C, Ma Q, Zeng Q, Wang H, Cheng Z, Zhu G, Qi J, Ma H, Nian H (2014) RNA-seq analyses of multiple meristems of soybean: novel and alternative transcripts, evolutionary and functional implications. BMC Plant Biol 14(1):1–19

    Article  Google Scholar 

  19. Langfelder P, Horvath S (2008) WGCNA: an r package for weighted correlation network analysis. BMC Bioinformatics 9:559

    Article  Google Scholar 

  20. da Huang W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4(1):44–57

    Article  CAS  Google Scholar 

  21. Pan X, Jin X, Wang J, Hu Q, Dai B (2021) Placenta inflammation is closely associated with gestational diabetes mellitus. Am J Transl Res 13(5):4068–4079

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Tibshirani R (1997) The lasso method for variable selection in the cox model. Stat Med 16(4):385–395

    Article  CAS  Google Scholar 

  23. Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA (2018) Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol 1711:243–259

    Article  CAS  Google Scholar 

  24. Shabani F, Farasat A, Mahdavi M, Gheibi N (2018) Calprotectin (S100A8/S100A9): a key protein between inflammation and cancer. Inflamm Res 67(10):801–812

    Article  CAS  Google Scholar 

  25. Li H, Huang X, Chang X, Yao J, He Q, Shen Z, Ji Y, Wang K (2020) S100–A9 protein in exosomes derived from follicular fluid promotes inflammation via activation of NF-κB pathway in polycystic ovary syndrome. J Cell Mol Med 24(1):114–125

    Article  CAS  Google Scholar 

  26. Bi X, Zhai Z, Wang S (2019) Identification of the key pathways and genes related to polycystic ovary syndrome using bioinformatics analysis. Gen Physiol Biophys 38(3):205–214

    Article  CAS  Google Scholar 

  27. Wu X, Yu T, Ji N, Huang Y, Gao L, Shi W, Yan Y, Li H, Ma L, Wu K, Wu Z (2019) IL6R inhibits viability and apoptosis of pancreatic beta-cells in type 2 diabetes mellitus via regulation by miR-22 of the JAK/STAT signaling pathway. Diabetes Metab Syndr Obes 12:1645–1657

    Article  CAS  Google Scholar 

  28. Høgdall D, O’Rourke CJ, Dehlendorff C, Larsen OF, Jensen LH, Johansen AZ, Dang H, Factor VM, Grunnet M, Mau-Sørensen M, Oliveira D, Linnemann D, Boisen MK, Wang XW, Johansen JS, Andersen JB (2020) Serum IL6 as a prognostic biomarker and IL6R as a therapeutic target in biliary tract cancers. Clin Cancer Res 26(21):5655–5667

    Article  Google Scholar 

  29. Qin Z, Wang PY, Wan JJ, Zhang Y, Wei J, Sun Y, Liu X (2020) MicroRNA124-IL6R mediates the effect of nicotine in inflammatory bowel disease by shifting Th1/Th2 balance toward Th1. Front Immunol 11:235

    Article  CAS  Google Scholar 

  30. Zhang H, Kong Q, Wang J, Jiang Y, Hua H (2020) Complex roles of cAMP-PKA-CREB signaling in cancer. Exp Hematol Oncol 9(1):32

    Article  CAS  Google Scholar 

  31. Sirotkin AV, Balazi A, Chrenek P (2014) The cAMP analogue, dbcAMP, affects rabbit ovarian cell proliferation, apoptosis, release of steroids and response to hormones. Folia Biol (Krakow) 62(3):211–218

    Article  CAS  Google Scholar 

  32. Huang H, Wang Y, Kandpal M, Zhao G, Cardenas H, Ji Y, Chaparala A, Tanner EJ, Chen J, Davuluri RV, Matei D (2020) FTO-Dependent N (6)-methyladenosine modifications inhibit ovarian cancer stem cell self-renewal by blocking camp signaling. Cancer Res 80(16):3200–3214

    Article  CAS  Google Scholar 

  33. Raker VK, Becker C, Steinbrink K (2016) The cAMP pathway as therapeutic target in autoimmune and inflammatory diseases. Front Immunol 7:123

    Article  Google Scholar 

  34. Liew PX, Kubes P (2019) The neutrophil’s role during health and disease. Physiol Rev 99(2):1223–1248

    Article  CAS  Google Scholar 

  35. Yilmaz MA, Duran C, Basaran M (2016) The mean platelet volume and neutrophil to lymphocyte ratio in obese and lean patients with polycystic ovary syndrome. J Endocrinol Invest 39(1):45–53

    Article  CAS  Google Scholar 

  36. Bryceson YT, March ME, Ljunggren HG, Long EO (2006) Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 107(1):159–166

    Article  CAS  Google Scholar 

  37. Morante-Palacios O, Fondelli F, Ballestar E, Martínez-Cáceres EM (2021) Tolerogenic dendritic cells in autoimmunity and inflammatory diseases. Trends Immunol 42(1):59–75

    Article  CAS  Google Scholar 

  38. Li L, Liu X, Sanders KL, Edwards JL, Ye J, Si F, Gao A, Huang L, Hsueh EC, Ford DA, Hoft DF, Peng G (2019) TLR8-mediated metabolic control of human treg function: a mechanistic target for cancer immunotherapy. Cell Metab 29(1):103-123.e5

    Article  CAS  Google Scholar 

  39. Lian J, Yue Y, Yu W, Zhang Y (2020) Immunosenescence: a key player in cancer development. J Hematol Oncol 13(1):151

    Article  Google Scholar 

  40. Chalaris A, Rabe B, Paliga K, Lange H, Laskay T, Fielding CA, Jones SA, Rose-John S, Scheller J (2007) Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils. Blood 110(6):1748–1755

    Article  CAS  Google Scholar 

  41. Pan X, Jin X, Wang J, Hu Q, Dai B (2021) Placenta inflammation is closely associated with gestational diabetes mellitus. Am J Translational Res 13(5):4068–4079

    CAS  Google Scholar 

Download references

Funding

This work was supported by National Natural Science Foundation of China (Program No. 82172714), Natural Science Foundation of Shanghai (Program No. 20ZR1443900).

Author information

Authors and Affiliations

Authors

Contributions

JQ carried out the Conception and design of the research, XT and MQ participated in the Acquisition of data. XT and JW carried out the Analysis and interpretation of data. ZC and KL participated in the design of the study and performed the statistical analysis. JQ and BL conceived of the study, and participated in its design and coordination and helped to draft the manuscript and revision of manuscript for important intellectual content. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Xiaoming Teng.

Ethics declarations

Conflict of interests

The authors declare that they have no conflict of interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qu, J., Li, B., Qiu, M. et al. Discovery of immune-related diagnostic biomarkers and construction of diagnostic model in varies polycystic ovary syndrome. Arch Gynecol Obstet 306, 1607–1615 (2022). https://doi.org/10.1007/s00404-022-06686-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-022-06686-y

Keywords

Navigation